European Market Research

 
News Articles for European Market Research top ^
RHB-102, newly branded as BEKINDA ™ , is a proprietary once-daily oral pill formulation of the antiemetic drug ondansetron The European marketing authorization application (MAA) seeks approval of BEKINDA ™ for cancer patients suffering from chemotherapy and radiotherapy-induced nausea and vomiting BEKINDA ™ is also being developed for acute gastroenteritis and gastritis, with a Phase III study ongoing in the U.S. and top-line data expected during H2/2015 TEL-AVIV, Israel, Dec.
Sign-up for RedHill Biopharma Submits BEKINDA(TM) (RHB-102) European Marketing Authorization Application for Oncology Support investment picks
The German Federal Institute for Drugs and Medical Devices ("BfArM") has validated the European Marketing Authorization Application submitted for RIZAPORT™ and initiated its formal review of the application on November 25, 2014 IntelGenx and RedHill continue to work with the FDA to resolve the remaining Chemistry, Manufacturing and Controls ("CMC") issues and secure a compliant source of the raw material, in order to advance potential FDA approval of the U.S. New Drug Application submitted by the companies RIZAPORT™ oral thin film formulation of rizatriptan for acute migraines presents an attractive therapeutic alternative for many migraine patients, including those suffering from migraine-related nausea, due to its convenient dosing, lack of need for water intake and pleasant flavoring  SAINT LAURENT, Quebec, Dec.
Sign-up for IntelGenx and RedHill Biopharma Announce Acceptance for Review of European Marketing Application for RIZAPORT(TM) for Migraines investment picks
The German Federal Institute for Drugs and Medical Devices (BfArM) has validated the European Marketing Authorization Application submitted for RIZAPORT ™ (RHB-103) and initiated its formal review of the application on November 25, 2014 RedHill and IntelGenx continue to work with the FDA to resolve the remaining Chemistry, Manufacturing and Controls (CMC) issues and secure a compliant source of the raw material, in order to advance potential FDA approval of the U.S. New Drug Application submitted by the companies RIZAPORT ™ oral thin film formulation of rizatriptan for acute migraines presents a potentially attractive therapeutic alternative for many migraine patients, including those suffering from migraine-related nausea, due to its convenient dosing, lack of need for water intake and pleasant flavoring TEL-AVIV, Israel, Dec.
Sign-up for RedHill Biopharma and IntelGenx Announce Acceptance for Review of European Marketing Application for RIZAPORT(TM) for Migraines investment picks
2014/12/4
To an audience of more than 450 leaders at its European Commercial Summit, Veeva Systems announced the availability of the Veeva Network Provider Database for Europe, beginning with the top five markets.
Sign-up for Veeva Systems Announces Healthcare Professional and Healthcare Organization Data Offering for the European Market investment picks
2014/12/2
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks rose Tuesday, on track to snap two sessions of losses as energy issues caught a break after a recent patch of relentless selling.
Sign-up for EUROPE MARKETS: Energy Stocks Drive European Market Higher investment picks
Successful Pre-Submission Meeting with European Medicines Agency Completed CRANBURY, N.J., Dec.
Sign-up for Amicus Therapeutics to Submit European Marketing Application for Migalastat Monotherapy for Fabry Disease investment picks
2014/12/2
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks rose Tuesday, on track to snap two sessions of losses as energy issues caught a break after a recent patch of relentless selling.
Sign-up for Energy stocks drive European market higher investment picks
High performance, specialty connectors available with shortened lead time, lower cost ORLANDO, Fla.
Sign-up for API Technologies Offers Filtered Circular Connectors Direct to the European Market investment picks
2014/12/10
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Greek stocks extended losses Wednesday, with political turmoil fueling a selloff that left the Greek equity benchmark with its worst decline on record in the previous session.
Sign-up for Greek stock selloff resumes, as European markets recover investment picks
2014/12/10
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Greek stocks extended losses Wednesday, as political worries continued to fuel a selloff.
Sign-up for UPDATE: Greek stock selloff resumes, as European markets recover investment picks
Sierra Wireless (NASDAQ:SWIR) (TSX:SW) today announced the launch of AirLink® Enterprise Connect, a first-of-its-kind bundled solution for retail and branch locations in the United Kingdom, France, and Germany.
Sign-up for New Sierra Wireless Solution Bundle Delivers 4G LTE Connectivity for Retailers and Branch Locations in Major European Markets investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

European Market Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: European Investing  |  Next: European Media Enterprises